News

Ceragon Unveils Game-Changing IP-50EXP Millimeter Wave Solution

Ceragon Unveils Game-Changing IP-50EXP Millimeter Wave Solution

Ceragon Unveils New IP-50EXP Solution for Advanced Connectivity

New solution offers power and flexibility for a full range of high-capacity wireless scenarios.

Ceragon, a key player in delivering end-to-end wireless connectivity, has launched a remarkable product—its latest E-band solution, the IP-50EXP. This new offering builds on the already successful IP-50EX line, effectively tackling a stubborn challenge commonly faced in E-band solutions: delivering long link distances while ensuring ultra-high capacity and affordability.

Featuring an industry-leading combination of performance metrics and economic viability, the IP-50EXP solidifies Ceragon's stature as an innovative force in 5G technology.

Innovative Features of the IP-50EXP

The IP-50EXP introduces significant advancements in several key areas:

Extensive Link Distance and High Reliability

The product encompasses extended Tx power reaching up to 24 dBm and low RSL thresholds. Coupled with an optional 2 or 3 ft E-stabilizer antenna, the IP-50EXP achieves link distances comparable to traditional microwave radio systems. Furthermore, adaptive coding modulation and bandwidth (ACMB) technology contribute to its high network resiliency, even when operating under difficult conditions.

Support for 5G Network Expansion

With impressive capacity of up to 20 Gbps in a 2+0 configuration, this solution is fully aligned with SyncE and IEEE1588v2 standards, making it incredibly suitable for 5G network enhancements.

Versatile and Ready for Applications

The IP-50EXP is meticulously designed to meet diverse network requirements, successfully balancing extended reach with high-speed performance. This versatility makes it an attractive choice for various deployment scenarios.

Simple Deployment Process

To expedite alignment and installation, the IP-50EXP comes equipped with state-of-the-art setup technologies and a user-friendly graphical interface.

Enhanced Security and Scalability

Incorporating advanced security features and dual 25 GbE interfaces, the IP-50EXP guarantees secure data transfers while laying down the necessary groundwork for scalable networking that aligns with the anticipated growth of mobile networks.

"The IP-50EXP sets a new standard for high-capacity E-band solutions by providing remarkable link distances and enabling network operators to enhance their 5G service areas intelligently and economically," said Ulik Broida, Chief Product Officer at Ceragon. "Our strong reception from top-tier customers actively demonstrates our ongoing commitment to delivering cutting-edge solutions that cater to our clients' evolving technical and economic demands."

Explore the IP-50EXP Today

For those eager to learn more about the IP-50EXP or to consult with an expert, please reach out through our site.

About Ceragon

Ceragon stands at the forefront of wireless connectivity innovation, specializing in robust solutions that encompass transport, access, and AI-driven managed services. Our dedication to excellence enables clients to improve operational efficiency and amplify the quality of their offerings.

Our vast clientele ranges from service providers and utilities to public safety organizations and agencies, all of whom depend on our expertise for both 5G and 4G wireless connectivity and crucial services that require high reliability and speed. We proudly serve more than 600 service providers and over 1,600 private network operators worldwide, with solutions deployed across more than 130 countries. Ceragon’s holistic approach encompasses hardware, software, and comprehensive services that empower our customers to confidently embrace the future of wireless, shaping the next wave of connectivity.

For additional details, feel free to visit our website.

Frequently Asked Questions

What is the IP-50EXP solution?

The IP-50EXP is Ceragon's newest E-band solution, designed to provide high-capacity and long-distance wireless connectivity, particularly for 5G networks.

How does the IP-50EXP enhance wireless connectivity?

It offers extended link distances, high capacity up to 20 Gbps, and advanced security features, making it suitable for diverse applications.

Who can benefit from the IP-50EXP?

Service providers, utilities, and public safety organizations can utilize the IP-50EXP for various network demands and enhancements.

What makes the IP-50EXP unique?

Its combination of long link distances, superior capacity, and ease of deployment distinguishes it from other E-band solutions on the market.

Where can I find more information about Ceragon?

More details about Ceragon and its offerings can be found on their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 313

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 193

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 128

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 224

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 134

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 541

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 161

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Phreesia Announces Q3 Fiscal Year 2025 Financial Results

Updated Category News Views 71

Phreesia to Release Fiscal Q3 2025 Results Soon Phreesia, Inc. (NYSE: PHR) has great news for its stakeholders! The company revealed plans to announce its financial results for the third quarter of fiscal year 2025 right after market closing on a Monday in December. During this quarter, the firm experienced substantial growth and is eager to share the details with the...

Continue Reading
Innovative Water Bowl Design Enhances Pet Hydration Experience

Updated Category News Views 374

Revolutionary Pet Water Bowl Crafted for Optimal Hydration Every pet owner knows the importance of keeping their furry friends hydrated, especially during hot days. A new invention promises to enhance the experience for pets and their owners alike. This innovative water bowl, known as the THERMA DRINK, is designed with features that cater directly to pet needs. The idea...

Continue Reading
HPH's Leadership Changes Signify Strategic Direction Ahead

Updated Category News Views 177

Leadership Transitions at HPH Highest Performances Holdings Inc. (NASDAQ: HPH) has recently seen a notable change in its Board of Directors. The company announced that Mr. Peh Chin Hua's tenure as Director has come to an end, effective immediately. This decision is part of a broader strategy aimed at strengthening the Board's overall composition and capabilities. Current...

Continue Reading
Apranga Group Reports Growth in Retail Turnover for 2025

Updated Category News Views 132

Apranga Group Retail Performance Overview for 2025 Apranga Group, a major player in the retail sector, has announced its impressive financial performance for the first six months of 2025, demonstrating notable growth compared to the prior year. The company's retail turnover reached a commendable EUR 166.1 million, reflecting a 2.8% increase from the same period in 2024....

Continue Reading
IMUNON Unveils Promising New Vaccine Data for COVID-19

Updated Category News Views 154

New Vaccine Insights from IMUNON's Phase 1 Clinical Trial The innovative PlaCCine technology platform developed by IMUNON, Inc. (NASDAQ: IMNN) promises remarkable durability and advantages over traditional mRNA vaccines, particularly in the struggle against COVID-19. Robust Results from IMNN-101 Vaccine Trials In an encouraging announcement, IMUNON shared pivotal data...

Continue Reading